Literature DB >> 1356828

Antigen-specific cytolysis of infected cells in murine candidiasis.

L Romani1, S Mocci, E Cenci, A Mencacci, G Sbaraglia, P Puccetti, F Bistoni.   

Abstract

Immune L3T4+ and Lyt-2+ lymphocytes play an important role in the acquired resistance of mice to challenge with virulent Candida albicans, and release macrophage-activating cytokines in response to yeast cells in vitro. To determine whether antigen (Ag)-specific cytotoxic T lymphocytes are generated during fungal infection, purified L3T4+ and Lyt-2+ lymphocytes from immunized mice were cultured in the presence of syngeneic accessory cells, Candida Ag, and IL-2. Yeast-infected bone marrow macrophages and peritoneal exudate neutrophils were used as target cells in a standard 51Cr release assay. Ag-specific, MHC-unrestricted lysis of infected macrophages was evident with immune Lyt-2+ cells after 5-10 days in culture. Under the same experimental conditions, the cytotoxic activity of L3T4+ cells was negligible, but its expression could be induced by the addition of anti-CD3 antibody. Culturing immune Lyt-2+ cells for shorter periods of time (1-2 days) resulted in preferential lysis of infected neutrophils. In addition, at limiting effector cell numbers, Ag-specific MHC-restricted lymphocytes with cytotoxic activity to infected macrophages could be identified. We suggest that C. albicans infection stimulates multiple cytotoxic T-cell precursors with varying recognition stringency, which may have an important role in antifungal resistance in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356828     DOI: 10.1007/bf00158570

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  33 in total

1.  Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice.

Authors:  E Cenci; L Romani; A Vecchiarelli; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 2.  Chronic systemic candidiasis.

Authors:  G P Bodey; E J Anaissie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

3.  Candida albicans C3d receptor, isolated by using a monoclonal antibody.

Authors:  L Linehan; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  Development of large granular lymphocytes with anomalous, nonspecific cytotoxicity in clones derived from Ly-2+ T cells.

Authors:  K Shortman; A Wilson; R Scollay; W F Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

6.  Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes.

Authors:  J Y Djeu; D K Blanchard; A L Richards; H Friedman
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

7.  Selective synthesis of mRNA and proteins by human peripheral blood neutrophils.

Authors:  R M Jack; D T Fearon
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

8.  Candida albicans-specific Ly-2+ lymphocytes with cytolytic activity.

Authors:  L Romani; S Mocci; E Cenci; R Rossi; P Puccetti; F Bistoni
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

9.  Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity.

Authors:  S H Kaufmann; H R Rodewald; E Hug; G De Libero
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

10.  Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells.

Authors:  S H Kaufmann; E Hug; G De Libero
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.